Geneva, April 28 -- International Clinical Trials Registry received information related to the study (KCT0011866) titled 'Efficacy of Lecanemab in patients with Parkinson's disease with a positive amyloid PET scan' on April 17.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : Non-RCT
Primary Sponsor: Yonsei University Health System, Severance Hospital
Condition:
Diseases of the nervous system
Intervention:
Drug : This study plans to consecutively enroll the patients with Parkinson's disease (PD) who have confirmed amyloid deposition on amyloid imaging and meet the indications for lecanemab administration. After a thorough explanation o...